Risk factors associated to cardiometabolic diseases, such as high LDL cholesterol, blood sugar and high triglycerides levels are the most common pathologies worldwide with the higher impact on our health system.
Some interesting details
0
italian patent
0
published clinical studies
0
countries where it’s commercialized
Some interesting details
0
italian patent
0
published clinical studies
0
countries where it’s commercialized
Benefits:
- Less cholesterol absorption
- More cholesterol expel
- Less biosynthesis of cholesterol
- Less biosynthesis of triglycerides
- Increased uptake of blood glucose by cells
Italian patent n. IT0001422673
European patent pending n. EP3116520